FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to obstetrics and gynecology, and concerns treating diffuse benign breast dysplasia in females. That is ensured by digital mammography of mammary glands and determination of vitamin D. If observing the high density of mammary glands and the level of vitamin D below 30 ng/ml, 5,000 IU of vitamin D is administered once a day for a month. After the monthly course, the level of vitamin D is repeatedly determined, and when the level reaches no less than 45 ng/ml, the dose of vitamin is reduced to a maintenance value of 2,000 IU once a day. If the vitamin D levels are lower, the dosage is continued 5,000 IU once a day until reaching a value of at least 45 ng/ml and then switched to a maintenance dose. Total length of treatment is 6 months.
EFFECT: introduction of vitamin D in the above mode provides effective correction of its deficiency, reduced density of mammary gland and accordingly prevention of breast cancer.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING DIFFUSE MAMMARY DYSPLASIA IN FEMALES OF REPRODUCTIVE AGE | 2013 |
|
RU2548723C1 |
METHOD OF TREATING CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2456010C1 |
METHOD OF TREATING MASTOPATHY | 2023 |
|
RU2819077C1 |
METHOD FOR DETERMINING EFFECTIVENESS OF DOSE OF DIETARY SUPPLEMENT LIGNARIUS IN PATIENTS WITH FIBROCYSTIC MASTOPATHY | 2022 |
|
RU2806529C1 |
METHOD FOR TREATING MASTOPATHY | 2002 |
|
RU2226400C1 |
METHOD OF TREATING CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2456009C1 |
METHOD FOR CHOOSING A THERAPEUTIC DOSE OF CHOLECALCIFEROL FOR A PATIENT WITH INSUFFICIENT PROVISION OR VITAMIN D DEFICIENCY WHO HAS UNDERGONE BREAST CANCER | 2021 |
|
RU2762772C1 |
METHOD OF TREATING VEGETATIVE DYSFUNCTION ACCOMPANYING DIFFUSE CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2471494C2 |
METHOD FOR PREDICTION OF DEVELOPING COMPLICATIONS IN WOMEN SUFFERING CLIMACTERIC SYNDROME AND MASTOPATHY AND EMPLOYING HORMON REPLACEMENT | 2010 |
|
RU2426994C1 |
METHOD OF TREATMENT OF PATIENT WITH FIBROCYSTIC MASTOPATHY AND CYSTIC BREAST | 1999 |
|
RU2150293C1 |
Authors
Dates
2019-10-03—Published
2018-11-08—Filed